Preoperative total cholesterol and axillary lymph node burden in breast cancer: an exploratory analysis with a preliminary nomogram - Report - MDSpire

Preoperative total cholesterol and axillary lymph node burden in breast cancer: an exploratory analysis with a preliminary nomogram

  • By

  • Xingxing Ouyang

  • Lisha Wu

  • Yanhua Zhou

  • July 1, 2026

  • 0 min

Share

Clinical Report: Association of Preoperative Serum Total Cholesterol Levels with Axillary Lymph Node Involvement in Breast Cancer

Overview

This study investigates the relationship between preoperative serum total cholesterol levels and axillary lymph node burden in breast cancer patients. It finds that higher cholesterol levels are associated with increased odds of high axillary lymph node burden.

Background

Axillary lymph node status is a critical prognostic factor in breast cancer treatment planning. High axillary lymph node burden influences decisions regarding post-mastectomy therapies.

Data Highlights

ParameterValue
High ALN burden prevalence25%
Odds Ratio for TC increase1.56 per 1 mmol/L increase
95% Confidence Interval1.07–2.38
P-value0.026
Optimism-corrected C-index0.61

Key Findings

  • High ALN burden was found in 25% of the studied patients.
  • Higher preoperative total cholesterol levels were associated with increased odds of high nodal burden (OR = 1.56).
  • No significant association was observed in univariate analysis.
  • Inclusion of tumor size did not improve model fit.
  • The proposed model demonstrated limited discriminative ability.

Clinical Implications

Further research is needed to validate these findings in larger cohorts.

Conclusion

Preoperative total cholesterol levels may be associated with axillary nodal burden in breast cancer, but the exploratory nature of this study and its limitations necessitate further investigation.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. Resource Guide on Axillary Management for Patients With In-Situ and Invasive Breast Cancer: A Concise Overview
  6. SENOMAC Trial: Omission of Completion Axillary Dissection Is Oncologically Safe in Expanded Breast Cancer Population - The ASCO Post
  7. Accuracy of Deep Learning for Detecting Axillary Lymph Node Metastasis in Breast Cancer: Systematic Review and Meta-Analysis - PubMed
  8. Resource Guide on Axillary Management for Patients With In-Situ and Invasive Breast Cancer: A Concise Overview
  9. SENOMAC Trial: Omission of Completion Axillary Dissection Is Oncologically Safe in Expanded Breast Cancer Population - The ASCO Post
  10. Accuracy of Deep Learning for Detecting Axillary Lymph Node Metastasis in Breast Cancer: Systematic Review and Meta-Analysis - PubMed

Original Source(s)

Related Content